Lytix Biopharma As

This study tested a two-step treatment for people with advanced soft tissue sarcoma that had stopped responding to standard therapy. First, a drug was injected into a tumor to attract immune cells. Then, that tumor was removed, and the immune cells were grown in a lab and infused…

This study tested a drug called LTX-315, injected directly into accessible tumors, combined with the immunotherapy pembrolizumab (Keytruda) in 23 people with advanced melanoma that had stopped responding to prior PD-1/PD-L1 inhibitors. The goal was to see if this combination coul…